REGENXBIO Inc. revenue breakdown overview

REGENXBIO Inc. revenue for the last year amounted to 90.24 M USD, the most of which — 90.24 M USD — came from its highest performing source at the moment, Gene Therapy, the year earlier bringing 112.72 M USD. The greatest contribution to the revenue figure was made by International — last year it brought REGENXBIO Inc. 61.36 M USD, and the year before that — 62.00 M USD.